Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000235887 | SCV000293027 | uncertain significance | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000240437 | SCV000299169 | likely benign | Neuropathy, hereditary sensory and autonomic, type 2A; Generalized epilepsy with febrile seizures plus, type 7 | 2024-10-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765525 | SCV000896839 | uncertain significance | Primary erythromelalgia; Neuropathy, hereditary sensory and autonomic, type 2A; Paroxysmal extreme pain disorder; Severe myoclonic epilepsy in infancy; Channelopathy-associated congenital insensitivity to pain, autosomal recessive; Generalized epilepsy with febrile seizures plus, type 7 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001336522 | SCV001529924 | uncertain significance | Generalized epilepsy with febrile seizures plus, type 7 | 2018-11-08 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV002444935 | SCV002734391 | uncertain significance | Inborn genetic diseases | 2019-12-09 | criteria provided, single submitter | clinical testing | The p.T773S variant (also known as c.2318C>G), located in coding exon 14 of the SCN9A gene, results from a C to G substitution at nucleotide position 2318. The threonine at codon 773 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |